DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia

Clinical trial NCT07623525 · RECRUITING

Trial details

NCT number: NCT07623525
Sponsor: Diagonal Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hereditary Hemorrhagic Telangiectasia Pulmonary Arterial Hypertension

Start date: 2026-06-04
Primary completion: 2027-11-30
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.